SCHEMBL3911474

SCHEMBL3911474

O=C(CBr)NS

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23475924 0.72 TSHR (0.44)
SCHEMBL4969215 0.72 PHF8 (0.38)
SCHEMBL8580553 0.69
SCHEMBL23816237 0.69
SCHEMBL11395882 0.69
SCHEMBL6365235 0.67
SCHEMBL817079 0.67
SCHEMBL8579414 0.67
SCHEMBL10866810 0.67 HDAC3 (0.41)
SCHEMBL3917818 0.67

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 27 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20250302995-A1 OLIGONUCLEOTIDE COMPOSITIONS AND METHODS THEREOF SHIVALILA CHIKDU SHAKTI (US) 2025-10-02 US disclosed
EP-4522744-A1 OLIGONUCLEOTIDE COMPOSITIONS AND METHODS THEREOF Wave Life Sciences Ltd. (SG) 2025-03-19 EP disclosed
WO-2023220440-A1 OLIGONUCLEOTIDE COMPOSITIONS AND METHODS THEREOF WAVE LIFE SCIENCES LTD. (SG) 2023-11-16 WO disclosed
US-20230272391-A1 ADAR DEPENDENT EDITING COMPOSITIONS AND METHODS OF USE THEREOF ADARx Pharmaceutical, Inc. (US) 2023-08-31 US disclosed
EP-4189088-A1 ADAR DEPENDENT EDITING COMPOSITIONS AND METHODS OF USE THEREOF Adarx Pharmaceuticals, Inc. (US) 2023-06-07 EP disclosed
CN-116209762-A ADAR-dependent editing compositions and methods of use thereof 阿达尔克斯制药有限公司 2023-06-02 CN disclosed
EP-2068828-A2 BIODEGRADABLE OCULAR IMPLANTS AND METHODS FOR TREATING OCULAR CONDITIONS SurModics, Inc. (US) 2009-06-17 EP disclosed
EP-2015794-A2 HYDROPHILIC SHAPE MEMORY INSERTABLE MEDICAL ARTICLES SurModics, Inc. (US) 2009-01-21 EP disclosed
WO-2009005718-A1 POLYPEPTIDE MICROPARTICLES HAVING SUSTAINED RELEASE CHARACTERISTICS, METHODS AND USES SURMODICS, INC. (US) 2009-01-08 WO disclosed
EP-1937327-A1 NATURAL BIODEGRADABLE MATRICES AND USES THEREOF SurModics, Inc. (US) 2008-07-02 EP disclosed
US-20070218486-A1 Immunoassays, Haptens, Immunogens and Antibodies for Anti-HIV Therapeutics ARK DIAGNOSTICS, INC. (US) 2007-09-20 US disclosed
US-20070218486-A1 Immunoassays, Haptens, Immunogens and Antibodies for Anti-HIV Therapeutics ARK DIAGNOSTICS, INC. (US) 2007-09-20 US disclosed
WO-2007103740-A2 IMMUNOASSAYS, HAPTENS, IMMUNOGENS AND ANTIBODIES FOR ANTI-HIV THERAPEUTICS ARK DIAGNOSTICS (US) 2007-09-13 WO disclosed
WO-2007040557-A1 COATINGS AND ARTICLES INCLUDING NATURAL BIODEGRADABLE POLYSACCHARIDES SURMODICS, INC. (US) 2007-04-12 WO disclosed
WO-2007038126-A1 IN VIVO FORMED MATRICES INCLUDING NATURAL BIODEGRADABLE POLYSACCHARIDES AND OPHTHALMIC USES THEREOF SURMODICS, INC. (US) 2007-04-05 WO disclosed
WO-2007035886-A1 NATURAL BIODEGRADABLE MATRICES AND USES THEREOF SURMODICS, INC. (US) 2007-03-29 WO disclosed
WO-2007035865-A1 COATINGS AND ARTICLES INCLUDING NATURAL BIODEGRADABLE POLYSACCHARIDES SURMODICS, INC. (US) 2007-03-29 WO disclosed
EP-1755696-A1 NATURAL BIODEGRADABLE POLYSACCHARIDE COATINGS FOR MEDICAL ARTICLES SurModics, Inc. (US) 2007-02-28 EP disclosed
WO-2005115490-A2 NATURAL BIODEGRADABLE POLYSACCHARIDE COATINGS FOR MEICAL ARTICLES SURMODICS, INC. (US) 2005-12-08 WO disclosed
WO-2005113034-A1 NATURAL BIODEGRADABLE POLYSACCHARIDES COATINGS FOR MEDICAL ARTICLES SURMODICS, INC. (US) 2005-12-01 WO disclosed